IgA Nephropathy Therapeutics Analysis by Key Players Mallinckrodt Pharmaceuticals, Merck Group, Novartis, Shire
The study analyzed that the IgA nephropathy therapeutics pipeline comprises of 24 drug candidates in different stages of development. The report also includes epidemiology forecast for IgA Nephropathy for the period 2016 – 2025.Browse report sample at: https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis/report-sample
*Technological Advancements at Cellular and Molecular Level Strengthening the IgA Nephropathy Pipeline
Various new technologies are being used by the companies for the development of drugs to treat IgA nephropathy. For instance, TARGIT drug delivery technology is being used by Calliditas Therapeutics AB for the development of novel drug therapies.
Some of the key players developing drugs for the treatment of IgA nephropathy include Mallinckrodt plc, Merck KGaA, Novartis AG, and Shire plc.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=iga-nephropathy-pipeline-analysis
*Insights on Pipeline Segments
The pipeline involves drug candidates that are being developed using specific targets such as a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS). More than three drug candidates are being developed using subcutaneous route of administration.
Browse report at: https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis
*Promising Targets Spur the IgA Nephropathy Pipeline Growth
Companies are developing drugs with promising targets for the treatment of the disease. The potential targets may possibly stop or slow the progression of the disease with better efficacy and less side effects. Potential targets such as a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS), melanocortin receptors, and NF-κB signaling can also prove to be effective in IgA nephropathy treatment, since clinical trials of drug candidates meant to act on these targets have shown promising results. This is encouraging companies to further invest in their pipeline to develop drugs acting on new targets, thereby, fueling the growth of the pipeline.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
347 5th Ave. #1402- 210
New York City, NY 10016 United States
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release IgA Nephropathy Therapeutics Analysis by Key Players Mallinckrodt Pharmaceuticals, Merck Group, Novartis, Shire here
News-ID: 1400041 • Views: …
More Releases from P&S Intelligence
Public Safety and Security Market Size, Trends, and Forecast 2024-2032
The global public safety and security market is projected to grow from USD 517.6 billion in 2024 to USD 1,214.2 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.4% during the forecast period.
This growth is driven by technological advancements, such as artificial intelligence (AI) and the Internet of Things (IoT), which enhance smart city initiatives and improve surveillance and emergency response systems. The increasing incidence of…
Salesforce Services Market Growth Driven by BFSI Sector Demand
The global Salesforce services market reached a valuation of USD 14.1 billion in 2023 and is projected to grow significantly, reaching USD 48.3 billion by 2030. This robust growth is driven by increasing demand across the banking, financial services, and insurance (BFSI) sectors.
Salesforce CRM, known for its high-quality service offerings, supports streamlined operations, efficient communication, and enhanced customer service. It optimizes data management and expedites issue resolution, enabling businesses to…
Asset Integrity Management Market Share, Growth and Forecast Report, 2024-2030
According to the latest market research study published by P&S Intelligence, the asset integrity management market is projected to generate approximately USD 24.2 billion in revenue in 2024, with an expected compound annual growth rate of 5.9% from 2024 to 2030, reaching USD 34.1 billion by the end of the decade.
This growth is driven by global industrialization and urbanization, stringent workplace safety regulations, heightened environmental concerns over poorly maintained…
The Rise of Fake Image Detection Solutions: Key Market Insights and Future Trend …
The fake image detection market is projected to expand significantly, from an estimated USD 712.2 million in 2024 to USD 5,811.9 million by 2030, reflecting a robust compound annual growth rate (CAGR) of 41.9% from 2024 to 2030.
Fake images often involve post-production manipulation, where images are altered so subtly that distinguishing the modifications, such as swapped faces or forged signatures, becomes nearly impossible. The proliferation of AI technology and cloud…
More Releases for IgA
Europe IgA Nephropathy Market Growing at a Tremendous CAGR of 19.2% by 2028
Europe IgA Nephropathy market research report, principal attributes such as highest level of spirit, practical solutions, dedicated research and analysis, innovation, talent solutions, integrated approaches, most advanced technology and commitment plays a key role. All of these features are strictly applied while building this market report for a client. It presents a definite solution to obtain market insights with which businesses can think about market place clearly and thereby take…
IgA Antibody Market Significantly Stepping towards the Success Till 2027|Novarti …
The global IgA Antibody market size is projected to reach US$ 5.2 Billion by 2027, at a CAGR of 5.7% during 2021-2027. The central points that fuel the market development during the gauge time frame remember increment for geriatric populace and number of hemophilic patients, further developed immunoglobulin creation attributable to the rise of trend setting innovations, and upgraded cleaning methods. Besides, flood in pervasiveness infections, for example, ongoing provocative…
North America has been the Largest Global Identity Governance and Administration …
Global IGA market is on the rise due to increasing demand from enterprises to identify their users, control whatever they can access, and further audit their activities for security of information. Apart from this, since IGA also provides businesses with numerous supplementary functions, including auditing and policy management, its adoption by business leaders across industries, is expected to escalate in near future. The global IGA market is segmented on the…
Technological Advancements at Cellular and Molecular Level Strengthening the IgA …
The pipeline involves drug candidates that are being developed using specific targets such as a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS). More than three drug candidates are being developed using subcutaneous route of administration.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis
The study analyzed that the IgA nephropathy therapeutics pipeline comprises of 24 drug candidates in different stages of development. The report also includes epidemiology forecast for IgA Nephropathy for the…
IgA Nephropathy Exhibits Emerging Pipeline with 11+ Drug Candidates
The study analyzed that the IgA nephropathy pipeline comprises of 12 drug candidates, of which one drug candidate is in Phase III stage, five drug candidates are in Phase II stage and three drug candidates are in Pre-Clinical stage. Also, there are two inactive drug candidates and one discontinued drug candidate. IgA nephropathy, also known as Berger’s disease, is a kidney disorder that occurs when IgA antibody gets settled in…
IVU app keeps IGA visitors informed
IVU supplies guidance and information system for IGA 2017
Berlin, 4 April 2017 – This year’s International Garden Show will draw crowds to Berlin with flowers, indoor and outdoor exhibitions and events. An app created by IVU Traffic Technologies AG on behalf of the state of Berlin will help visitors to find their way around the site and discover the various attractions. The application also meets the special requirements of people…